Abstract

The p53 regulatory network is critically involved in preventing the initiation of cancer. In unstressed cells, p53 is maintained at low levels and is largely inactive, mainly through the action of its two essential negative regulators, HDM2 and HDMX. p53 abundance and activity are up-regulated in response to various stresses, including DNA damage and oncogene activation. Active p53 initiates transcriptional and transcription-independent programs that result in cell cycle arrest, cellular senescence, or apoptosis. p53 also activates transcription of HDM2, which initially leads to the degradation of HDMX, creating a positive feedback loop to obtain maximal activation of p53. Subsequently, when stress-induced post-translational modifications start to decline, HDM2 becomes effective in targeting p53 for degradation, thus attenuating the p53 response. To date, no clear function for HDMX in this critical attenuation phase has been demonstrated experimentally. Like HDM2, the HDMX gene contains a promoter (P2) in its first intron that is potentially inducible by p53. We show that p53 activation in response to a plethora of p53-activating agents induces the transcription of a novel HDMX mRNA transcript from the HDMX-P2 promoter. This mRNA is more efficiently translated than that expressed from the constitutive HDMX-P1 promoter, and it encodes a long form of HDMX protein, HDMX-L. Importantly, we demonstrate that HDMX-L cooperates with HDM2 to promote the ubiquitination of p53 and that p53-induced HDMX transcription from the P2 promoter can play a key role in the attenuation phase of the p53 response, to effectively diminish p53 abundance as cells recover from stress.

Highlights

  • HDMX as being overexpressed in diverse tumors, through a variety of mechanisms, including but not limited to gene amplification [18]

  • We show that, like HDM2, the HDMX gene contains a p53-responsive promoter in its first intron that drives the expression of mRNA transcripts with quantitatively and qualitatively different translation potential, which participate in an autoregulatory feedback loop to control the abundance and activity of p53 in cancer cells

  • Oncogenic, and Pharmacological p53-activating Signals Induce Transcription from the Endogenous p53-responsive HDMX-P2 Promoter—The results reported above clearly demonstrate that synthetic reporter constructs containing the novel HDMX-P2 promoter region do exhibit p53-dependent transcription of the reporter gene when transfected into cells

Read more

Summary

Introduction

HDMX as being overexpressed in diverse tumors, through a variety of mechanisms, including but not limited to gene amplification [18]. We show that, like HDM2, the HDMX gene contains a p53-responsive promoter in its first intron that drives the expression of mRNA transcripts with quantitatively and qualitatively different translation potential, which participate in an autoregulatory feedback loop to control the abundance and activity of p53 in cancer cells.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call